Cargando…
MTA2 sensitizes gastric cancer cells to PARP inhibition by induction of DNA replication stress
Poly (ADP-ribose) polymerase (PARP) inhibitor olaparib selectively kills cancer cells with BRCA-deficiency and is approved for BRCA-mutated breast, ovarian and pancreatic cancers by FDA. However, phase III study of olaparib failed to show a significant improvement in overall survival in patients wit...
Autores principales: | Shi, Jinwen, Zhang, Xiaofeng, Li, Jin'e, Huang, Wenwen, Wang, Yini, Wang, Yi, Qin, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313750/ https://www.ncbi.nlm.nih.gov/pubmed/34280886 http://dx.doi.org/10.1016/j.tranon.2021.101167 |
Ejemplares similares
-
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
por: King, David, et al.
Publicado: (2020) -
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
por: King, David, et al.
Publicado: (2023) -
RB loss sensitizes cells to replication-associated DNA damage after PARP inhibition by trapping
por: Zamalloa, Luis Gregory, et al.
Publicado: (2023) -
PARP inhibition impedes the maturation of nascent DNA strands during DNA replication
por: Vaitsiankova, Alina, et al.
Publicado: (2022) -
Structural basis for MTA1c-mediated DNA N6-adenine methylation
por: Chen, Jiyun, et al.
Publicado: (2022)